Pathway Choice Prime (NY) 4-Year with ROP review

It depends on where you live. If you are a New York resident and want a clean 4-year fixed annuity without index complexity, the Pathway Choice Prime (NY) is a reasonable product. The automatic ROP rider and Extended Care Waiver add genuine value. If you live outside New York — or if you are a New York resident willing to comparison-shop national products that may offer higher guaranteed rates — this is not the most competitive option available.

The primary reason to buy this product is simplicity and certainty for New York residents. You lock in a fixed rate for four years, your premium is protected by a contractual return-of-premium guarantee, and if your health situation changes you have an exit valve through the Extended Care Waiver. The rate banding structure means the product works better as a vehicle for larger deposits — someone putting in $250,000 or more gets a materially better rate than someone at the $25,000 minimum. The 4-year structure is also short enough to feel manageable for someone who is not comfortable with long surrender commitments.

I think this product fits best for a New York resident in their late 50s to mid-70s who has a meaningful chunk of conservative money — ideally $100,000 or more — that they want guaranteed for the next four years without any market exposure. The wide issue-age range (18-90) is worth noting, but the product logic is most sensible for someone near or in retirement who values preservation over growth. It is less suitable for a younger accumulation buyer, for someone who might need the money before year four, or for someone shopping nationally who can access better rates elsewhere.

You are buying a four-year guaranteed interest rate backed by The United States Life Insurance Company in the City of New York, which carries an A (Excellent) rating from A.M. Best. The rate is fixed from the issue date — it does not float or reset annually — and interest accrues on a set schedule through the end of the surrender period. The ROP rider is included automatically and means that if you ever exercise a full surrender, you will receive at least your original premium back, even if surrender charges would otherwise have pushed the value below that. In practice, the ROP backstop is most relevant in the early years when surrender charges are steepest. By year four, the accumulated value should comfortably exceed the original premium at most rate levels anyway.

The crediting method is fixed interest only — no indices, no participation rates, no caps. Rates are banded by initial premium: three tiers exist at below $100,000, $100,000, and $250,000. As of the data available, those tiers run at 3.70%, 4.20%, and 4.25% respectively, guaranteed for the full four years. An upcoming rate revision effective May 11, 2026 moves those to 3.80%, 4.30%, and 4.35%. The product is also classified as an FPDA (flexible premium deferred annuity), which means additional contributions are accepted within the first 60 days of the contract — a somewhat unusual feature for a MYGA. Minimum additional premium is $100.

The contract is issued under New York's regulatory framework, which adds some consumer protections compared to contracts filed in other states but also limits distribution to New York residents.

The secondary feature that earns attention here is the Extended Care Waiver. If the annuitant is confined to a qualified care facility for at least 90 consecutive days, surrender charges are waived. That is not a long-term care benefit — it does not pay for care — but it does mean the money becomes accessible without penalty if health intervenes. For someone who is conservative enough to be buying a guaranteed-rate annuity in the first place, the extended-care waiver reduces one of the main anxieties about locking money up: what happens if I need it while I'm in a facility? The Terminal Illness Waiver works similarly — a certified terminal illness diagnosis triggers waiver of surrender charges. Together, these two provisions make the four-year commitment feel less rigid than the surrender schedule would suggest on paper.

The 4-year surrender schedule runs 9%, 8%, 7%, 6% — declining each year. Free withdrawals of up to 10% of the previous Account Anniversary Value are available beginning after the first contract year, with a minimum $2,000 balance requirement. No MVA applies to this contract, which is a meaningful distinction for buyers who worry about interest-rate-driven adjustments on top of surrender charges.

RMDs attributable to the contract are treated as friendly — the FPDA structure and the fact that the product specifically calls out RMD treatment in the spec suggests it is positioned as a qualified-account option. For someone holding this in an IRA, that matters. Systematic withdrawal options should be confirmed directly with the carrier for a qualifying distribution plan.

There is no base contract fee. There is no income rider fee. The ROP rider is included at no separate charge. This is a fee-clean product in the traditional sense — the carrier's margin is built into the spread between the crediting rate and what the underlying portfolio earns.

The main structural tradeoff is rate competitiveness. Nationally marketed MYGAs of similar or shorter duration often post higher guaranteed rates than the entry-level band here. The gap narrows as premium size grows — at $250,000, the rate becomes more competitive within the New York market specifically, where product choice is also more limited than nationally. The second tradeoff is the FPDA structure: the 60-day additional-premium window is useful if you plan to make a second contribution, but it also means the contract can shift bands after issue if additional premium pushes the total over a tier threshold. Confirming how the carrier handles mid-contract band changes is worth a call to the agent if you plan to use that feature.

Legal Entity: The United States Life Insurance Company in the City of New York

Parent: Corebridge Financial

A.M. Best Rating: A